Chemed (CHE) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CHE quarterly Cash Flow →
Cash flow data covering Chemed–Dec 31 2021 offers a view into how Dec 31 2025's cash position has developed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income265.24
Depreciation & amortization64.84
Amortization of Other Assets0.32
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets to be Disposed of0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.65
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation33.79
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Depreciation Amortization Of Intangibles And Stock Award-
Litigation Settlement Expense-
Amortization Of Restricted Stock Awards-
Loss On Sale Of Transportation Equipment-
Ununtilized Cares Act Grant Operating Activity-
Deferred Payroll Taxes-
Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash4.89
Increase Decrease In Lease Assets And Liabilities-0.81
Income taxes-11.70
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-11.60
Increase (Decrease) in Accounts Payable-5.19
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense-0.84
Other Working Capital47.26
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.43
Discontinued operations0.00
Net Cash flow from Operating Activities388.27
Investing Activities
Capital Expenditures-62.80
Sale of Capital Items4.57
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-0.23
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-0.89
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-59.34
Financing Activities
Short-term debt Net10.97
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-404.35
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-7.69
Net Increase Decrease Of Revolving Line Of Credit-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-31.70
Net Cash Flow from Financing Activities-432.77
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow330.04
Total Cash Flow-103.84
4 historic quarters locked

Sign in to unlock the full Chemed cash flow history.

About Chemed Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001562762-26-000020

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License